Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,159 | 2,637 | 2,578 | 2,266 | 2,736 |
| Cost of Goods | 1,106 | 1,226 | 1,218 | 991 | 1,149 |
| Gross Profit | 1,053 | 1,411 | 1,360 | 1,275 | 1,587 |
| Operating Expenses | 2,706 | 1,952 | 2,380 | 3,383 | 2,754 |
| Operating Income | -1,547 | -315 | -802 | -1,117 | -1,018 |
| Interest Expense | 7 | 7 | 10 | 11 | 13 |
| Other Income | -7 | 3 | 10 | 2 | 494 |
| Pre-tax Income | -1,561 | -319 | -802 | -1,126 | -537 |
| Net Income Continuous | -1,561 | -319 | -802 | -1,126 | -537 |
| Net Income Discontinuous | -406 | -723 | -360 | N/A | N/A |
| Minority Interests | 63 | 61 | 60 | 60 | 59 |
| Net Income | $-2,030 | $-1,103 | $-1,222 | $-1,186 | $-596 |
| EPS Basic Total Ops | -0.19 | -0.12 | -0.11 | -0.12 | -0.06 |
| EPS Basic Continuous Ops | -0.15 | -0.05 | -0.08 | -0.11 | -0.05 |
| EPS Basic Discontinuous Ops | -0.04 | -0.08 | -0.03 | N/A | N/A |
| EPS Diluted Total Ops | -0.19 | -0.12 | -0.11 | -0.12 | -0.06 |
| EPS Diluted Continuous Ops | -0.15 | -0.05 | -0.08 | -0.11 | -0.05 |
| EPS Diluted Discontinuous Ops | -0.04 | -0.08 | -0.03 | N/A | N/A |
| EBITDA(a) | $-1,455 | $-225 | $-749 | $-1,061 | $-965 |